Sentence examples for be high for malignant from inspiring English sources

Although the accuracy of the classification of main underlying cause of death has been found to be high for malignant diseases in the Swedish Cause-of-death registers [ 30, 32], some leukemia/myeloma deaths may have been erroneously classified as non-cancer-related or vice versa.

We found that this ratio was higher for the large particles in malignant cases (Table  3); these microcalcifications were pointier and rough, as reported in the literature.

Among the diagnostic groups, 5-year survival was highest for retinoblastoma (98% (95 100)), other malignant epithelial neoplasms and melanomas (93% (90 96)) and lymphomas (90% (87 92)).

The attributable cost of 30-day unplanned readmission was highest for heart disease (US$3,199,418), followed by pneumonia, malignant neoplasms, septicaemia, and chronic liver disease and cirrhosis (Table 4).

The percentage of nuclei positive for Mcm2 was higher in malignant tissue (median 76.5%, range 42 92%) than that in benign tissue (median 5%, range 0 33%) (P<0.0005).

The percentage of nuclei positive for Mcm2 was higher in malignant tissue (median 76.5%, range 42 92%) than in benign tissue (median 5%, range 0 33%) (P<0.0005), with similar results for Mcm5.

Similarly, the percentage of nuclei positive for Mcm5 was higher in malignant strictures (median 91%, range 84 95%, n=5) than in benign strictures (median 4%, range 3 8%, n=5) (not shown).

The immunofluorometric Mcm5 level results in bile were corroborated by immunohistochemistry data, which showed that the percentage of nuclei positive for Mcm2 and -5 was higher in malignant strictures than benign strictures.

Although the percentage of missing values was substantially higher for malignant melanoma, the results for T-stage were comparable for both breast cancer and melanoma.

In contrast, APRIL immunoreactive expression was higher in non-malignant as compared to malignant breast structures.

For example, the degree of quantitative precision that is required to assess risk for rare idiosyncratic liver failure surrounding a new treatment for a non-life threatening disorder of recurrent mild symptoms is higher than for a highly malignant tumor with a poor prognosis.